SciELO - Scientific Electronic Library Online

 
vol.19 número3Efectos a largo plazo de la COVID-19: una revisión de la literatura índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Acta médica Grupo Ángeles

versão impressa ISSN 1870-7203

Resumo

MORALES FERNANDEZ, José Antonio et al. Pharmacological treatments for COVID-19. Acta méd. Grupo Ángeles [online]. 2021, vol.19, n.3, pp.408-420.  Epub 04-Abr-2022. ISSN 1870-7203.

SARS-CoV-2 is the coronavirus that causes coronavirus disease 2019 (COVID-19), which is a disease of global concern and declared as a pandemic in 2020. For adequate control, personal protection measures have been taken and a great variety of drugs have been investigated to act in the pathogenic process to prevent the adhesion, replication and progression of the virus in the different stages of the disease, as well as the generation of effective neutralizing antibodies against it. The emergence of genetic variants has generated the need for advances in technologies for the development and research of new therapeutic targets. Currently, there is no specific drug for the pharmacological treatment of COVID-19, however, different drugs are used that have prevented the progression of the disease, recovery of illness, decreased mortality and increased survival.

Palavras-chave : SARS-CoV-2; COVID-19; coronavirus; treatment; pharmacological targets.

        · resumo em Espanhol     · texto em Espanhol